Santiago Pellejero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Santiago Pellejero has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- S. Lozares
Complejo Hospitalario de Navarra, Pamplona, Navarra
9 shared publications S Miquelez
Complejo Hospitalario de Navarra, Pamplona, Navarra
7 shared publicationsA Rubio
Complejo Hospitalario de Navarra, Pamplona, Navarra
6 shared publicationsF Maneru
Complejo Hospitalario de Navarra, Pamplona, Navarra
6 shared publicationsJ Olasolo
Complejo Hospitalario de Navarra, Pamplona, Navarra
6 shared publicationsM Martin
Complejo Hospitalario de Navarra, Pamplona, Navarra
6 shared publications
Latest Publications
- Open Access
Review on Treatment Planning Systems for Cervix Brachytherapy (Interventional Radiotherapy): Some Desirable and Convenient Practical Aspects to Be Implemented from Radiation Oncologist and Medical Physics Perspectives
Intracavitary brachytherapy (BT, Interventional Radiotherapy, IRT), plays an essential role in the curative intent of locally advanced cervical cancer, for which the conventional approach involves external beam radiotherapy with concurrent chemotherapy followed by BT. This work aims to review the different methodologies used by commercially available treatment planning systems (TPSs) in exclusive magnetic resonance imaging-based (MRI) cervix BT with interstitial component treatments. Practical aspects and improvements to be implemented into the TPSs are discussed. This review is based on the clinical expertise of a group of radiation oncologists and medical physicists and on interactive demos provided by the software manufacturers. The TPS versions considered include all the new tools currently in development for future commercial releases. The specialists from the supplier companies were asked to propose solutions to some of the challenges often encountered in a clinical environment through a questionnaire. The results include not only such answers but also comments by the authors that, in their opinion, could help solve the challenges covered in these questions. This study summarizes the possibilities offered nowadays by commercial TPSs, highlighting the absence of some useful tools that would notably improve the planning of MR-based interstitial component cervix brachytherapy.
Open AccessReview on Treatment Planning Systems for Cervix Brachytherapy (Interventional Radiotherapy): Some Desirable and Convenient Practical Aspects to Be Implemented from Radiation Oncologist and Medical Physics Perspectives
Intracavitary brachytherapy (BT, Interventional Radiotherapy, IRT), plays an essential role in the curative intent of locally advanced cervical cancer, for which the conventional approach involves external beam radiotherapy with concurrent chemotherapy followed by BT. This work aims to review the different methodologies used by commercially available treatment planning systems (TPSs) in exclusive magnetic resonance imaging-based (MRI) cervix BT with interstitial component treatments. Practical aspects and improvements to be implemented into the TPSs are discussed. This review is based on the clinical expertise of a group of radiation oncologists and medical physicists and on interactive demos provided by the software manufacturers. The TPS versions considered include all the new tools currently in development for future commercial releases. The specialists from the supplier companies were asked to propose solutions to some of the challenges often encountered in a clinical environment through a questionnaire. The results include not only such answers but also comments by the authors that, in their opinion, could help solve the challenges covered in these questions. This study summarizes the possibilities offered nowadays by commercial TPSs, highlighting the absence of some useful tools that would notably improve the planning of MR-based interstitial component cervix brachytherapy.
- 1 September 2020
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 25 (5) , 832-839
Consensus statement from the Spanish Brachytherapy Group (GEB) on accelerated partial breast irradiation using multicatheter interstitial brachytherapy
Aim: To establish consensus guidelines for a safe clinical practice of accelerated partial breast irradiation (APBI) interstitial multicatheter brachytherapy (BT). Background: APBI with interstitial multicatheter BT has proved to be effective in the treatment of early stage breast cancer. This paradigm shift in the approach to early breast cancer conservative treatment, along with the existing controversies on the clinical practice of APBI, prompted the Spanish Brachytherapy Group (GEB) of the Spanish Societies of Radiation Oncology (SEOR) and Medical Physics (SEFM) to address BT APBI in a consensus meeting. Materials and methods: Prior to the meeting, a survey with 27 questions on indication, inclusion criteria, BT modality, implant technique, image guidance and simulation, CTV and OAR definition, dose prescription and fractionation, dose calculation, implant quality metrics and OAR dose constrains was distributed. Items not reaching a level of agreement of 70% were discussed and voted during the meeting. Results: 26 Institutions completed the survey, 60% of them perform APBI procedures. The analysis of the survey showed consensus reached on approximately half the questions. An expert panel discussed the remaining items; thereafter, a voting established the definite consensus. Conclusions: This document summarizes the consensus guidelines agreed during the meeting of the Spanish Brachytherapy Group SEOR-SEFM. Institutions with BT facilities available should offer interstitial BT APBI as a treatment option to patients fulfilling the inclusion criteria. Institutions willing to implement interstitial BT APBI are encouraged to follow the consensus guidelines established herein. (C) 2020 Published by Elsevier B.V. on behalf of Greater Poland Cancer Centre.
- 1 September 2020
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 25 (5) , 832-839
Consensus statement from the Spanish Brachytherapy Group (GEB) on accelerated partial breast irradiation using multicatheter interstitial brachytherapy
Aim: To establish consensus guidelines for a safe clinical practice of accelerated partial breast irradiation (APBI) interstitial multicatheter brachytherapy (BT). Background: APBI with interstitial multicatheter BT has proved to be effective in the treatment of early stage breast cancer. This paradigm shift in the approach to early breast cancer conservative treatment, along with the existing controversies on the clinical practice of APBI, prompted the Spanish Brachytherapy Group (GEB) of the Spanish Societies of Radiation Oncology (SEOR) and Medical Physics (SEFM) to address BT APBI in a consensus meeting. Materials and methods: Prior to the meeting, a survey with 27 questions on indication, inclusion criteria, BT modality, implant technique, image guidance and simulation, CTV and OAR definition, dose prescription and fractionation, dose calculation, implant quality metrics and OAR dose constrains was distributed. Items not reaching a level of agreement of 70% were discussed and voted during the meeting. Results: 26 Institutions completed the survey, 60% of them perform APBI procedures. The analysis of the survey showed consensus reached on approximately half the questions. An expert panel discussed the remaining items; thereafter, a voting established the definite consensus. Conclusions: This document summarizes the consensus guidelines agreed during the meeting of the Spanish Brachytherapy Group SEOR-SEFM. Institutions with BT facilities available should offer interstitial BT APBI as a treatment option to patients fulfilling the inclusion criteria. Institutions willing to implement interstitial BT APBI are encouraged to follow the consensus guidelines established herein. (C) 2020 Published by Elsevier B.V. on behalf of Greater Poland Cancer Centre.
- 1 June 2020
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 22 (12) , 2350-2356
Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters
Purpose We analysed our initial experience with SBRT in liver metastasis from colorectal cancer at our institution. Materials and methods Between January/2014 and December/2017, 22 patients with 31 LMCCR were treated. Local control (LC) was assessed using the Kaplan–Meier and log-rank tests. We analysed potential prognostic factors for LC: sex, PTV size, number of LM and the radiation scheme. Results Median age: 69 years. Prior chemotherapy or local liver treatments: 81.8% and 63.6% of patients, respectively. SBRT consisted of 3 × 20 Gy (42.9%) and 3 × 15 Gy (31.4%). There were 88.5% responses (57.1% CR and 31.4% PR). Median follow-up was 30 months. LC per lesion at 12 and 24 months was 85.3% and 61.8%, respectively. Tumour volumes > 30 cc correlated with worsened 2-year-control rates (90% vs 34.5%) (p = 0.005). There was only a patient with CTC-grade 3 toxicity. Conclusions Liver SBRT is a safe and effective treatment that achieves high local control rates. We found a significant correlation between larger LMCRC and worse local control.
- 1 June 2020
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 22 (12) , 2350-2356
Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters
Purpose We analysed our initial experience with SBRT in liver metastasis from colorectal cancer at our institution. Materials and methods Between January/2014 and December/2017, 22 patients with 31 LMCCR were treated. Local control (LC) was assessed using the Kaplan–Meier and log-rank tests. We analysed potential prognostic factors for LC: sex, PTV size, number of LM and the radiation scheme. Results Median age: 69 years. Prior chemotherapy or local liver treatments: 81.8% and 63.6% of patients, respectively. SBRT consisted of 3 × 20 Gy (42.9%) and 3 × 15 Gy (31.4%). There were 88.5% responses (57.1% CR and 31.4% PR). Median follow-up was 30 months. LC per lesion at 12 and 24 months was 85.3% and 61.8%, respectively. Tumour volumes > 30 cc correlated with worsened 2-year-control rates (90% vs 34.5%) (p = 0.005). There was only a patient with CTC-grade 3 toxicity. Conclusions Liver SBRT is a safe and effective treatment that achieves high local control rates. We found a significant correlation between larger LMCRC and worse local control.
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part5) , 3234
SU-E-P-36: Evaluation of MLC Positioning Errors in Dynamic IMRT Treatments by Analyzing Dynalog Files
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part5) , 3234
SU-E-P-36: Evaluation of MLC Positioning Errors in Dynamic IMRT Treatments by Analyzing Dynalog Files
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part19) , 3446
SU-E-T-485: In Vivo Dosimetry with EBT3 Radiochromic Films for TBI Treatments
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part19) , 3446
SU-E-T-485: In Vivo Dosimetry with EBT3 Radiochromic Films for TBI Treatments
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part12) , 3336
SU-E-T-25: A Dosimetric Comparison of Three-Dimension Conformal and Intensity-Modulated Radiation Therapy in Esophageal Cancer
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part12) , 3336
SU-E-T-25: A Dosimetric Comparison of Three-Dimension Conformal and Intensity-Modulated Radiation Therapy in Esophageal Cancer
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part6) , 3246-3247
SU-E-I-24: Method for CT Automatic Exposure Control Verification
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part6) , 3246-3247
SU-E-I-24: Method for CT Automatic Exposure Control Verification
- 6 June 2013
- Published by Wiley in Medical Physics
- Vol. 40 (6Part20) , 350
SU-E-T-626: Three-Beam Technique for Intensity Modulated Radiation Therapy in Oesophagus: Dosimetric Differences in Organs at Risk
- 6 June 2013
- Published by Wiley in Medical Physics
- Vol. 40 (6Part20) , 350
SU-E-T-626: Three-Beam Technique for Intensity Modulated Radiation Therapy in Oesophagus: Dosimetric Differences in Organs at Risk
- 6 June 2013
- Published by Wiley in Medical Physics
- Vol. 40 (6Part4) , 122
SU-E-P-17: Development of An ImageJ Plugin for Image Quality Assurance in a CT Scanner
- 6 June 2013
- Published by Wiley in Medical Physics
- Vol. 40 (6Part4) , 122
SU-E-P-17: Development of An ImageJ Plugin for Image Quality Assurance in a CT Scanner